T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$1.62B |
| 2 |
SCHW
Charles Schwab
SCHW
|
+$1.61B |
| 3 |
Amazon
AMZN
|
+$1.18B |
| 4 |
Lam Research
LRCX
|
+$1.17B |
| 5 |
Las Vegas Sands
LVS
|
+$1.01B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Yum! Brands
YUM
|
+$1.4B |
| 2 |
Apple
AAPL
|
+$1.26B |
| 3 |
Tesla
TSLA
|
+$1.13B |
| 4 |
JPMorgan Chase
JPM
|
+$1.11B |
| 5 |
Morgan Stanley
MS
|
+$1.1B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.93% |
| 2 | Healthcare | 16.29% |
| 3 | Consumer Discretionary | 15.16% |
| 4 | Financials | 15.14% |
| 5 | Communication Services | 9.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ONC
451
BeOne Medicines Ltd
ONC
$40.3B
| $218M | 0.03% |
1,417,078
-2,572
| -0.2% | -$459K |
|
452
Sunstone Hotel Investors
SHO
$2.02B
| $216M | 0.03% |
13,005,966
+1,708,271
| +15% | +$27.8M |
|
453
Ultragenyx Pharmaceutical
RARE
$2.6B
| $215M | 0.03% |
2,796,392
+544,691
| +24% | +$35.2M |
|
|
JBGS
454
JBG SMITH
JBGS
$692M
| $215M | 0.03% |
5,892,685
+39,704
| +0.7% | +$1.44M |
|
455
Brown & Brown
BRO
$24B
| $215M | 0.03% |
7,743,483
+29,829
| +0.4% | +$812K |
|
456
FedEx
FDX
$80.3B
| $215M | 0.03% |
944,995
-89,361
| -9% | -$22.1M |
|
|
PX
457
DELISTED
Praxair Inc
PX
| $214M | 0.03% |
1,353,582
-24,060
| -2% | -$3.72M |
|
458
Sea Limited
SE
$75.5B
| $214M | 0.03% |
14,261,219
+1,086,715
| +8% | +$14M |
|
459
AXIS Capital
AXS
$7.3B
| $214M | 0.03% |
3,841,818
+1,133,368
| +42% | +$64.8M |
|
460
Ironwood Pharmaceuticals
IRWD
$674M
| $214M | 0.03% |
13,335,298
-1,243,980
| -9% | -$18.4M |
|
|
HOUS
461
DELISTED
Anywhere Real Estate
HOUS
| $213M | 0.03% |
9,343,676
+654,793
| +8% | +$16.3M |
|
462
Carnival Corporation Ltd
CCL
$38.9B
| $213M | 0.03% |
3,712,883
+271,319
| +8% | +$17.2M |
|
463
TAL Education Group
TAL
$6.43B
| $213M | 0.03% |
5,780,872
+777,179
| +16% | +$30.6M |
|
464
Sysco
SYY
$40B
| $212M | 0.03% |
3,101,876
+18,647
| +0.6% | +$1.19M |
|
465
Cadence Design Systems
CDNS
$89.2B
| $212M | 0.03% |
4,884,741
+4,022,972
| +467% | +$165M |
|
466
Bath & Body Works
BBWI
$3.76B
| $211M | 0.03% |
7,071,971
+1,641,449
| +30% | +$47.4M |
|
467
Pentair
PNR
$10.7B
| $210M | 0.03% |
5,001,167
-1,582,193
| -24% | -$71.1M |
|
|
WPX
468
DELISTED
WPX Energy, Inc.
WPX
| $210M | 0.03% |
11,662,838
+3,248,160
| +39% | +$55.6M |
|
469
Murphy Oil
MUR
$4.99B
| $210M | 0.03% |
6,217,747
-1,931,871
| -24% | -$59.6M |
|
470
Raymond James Financial
RJF
$34.8B
| $209M | 0.03% |
3,513,249
+1,859,995
| +113% | +$115M |
|
|
ESRX
471
DELISTED
Express Scripts Holding Company
ESRX
| $209M | 0.03% |
2,704,031
+408,155
| +18% | +$30.6M |
|
472
IBM
IBM
$223B
| $208M | 0.03% |
1,559,676
+5,549
| +0.4% | +$774K |
|
|
XLRN
473
DELISTED
Acceleron Pharma
XLRN
| $208M | 0.03% |
4,290,792
+662,570
| +18% | +$24.1M |
|
|
IMMU
474
DELISTED
Immunomedics Inc
IMMU
| $208M | 0.03% |
8,769,819
+1,790,358
| +26% | +$36M |
|
475
Ascendis Pharma A/S
ASND
$16.2B
| $206M | 0.03% |
3,099,099
+281,261
| +10% | +$18.5M |
|
Similar funds
T. Rowe Price Associates's Q2 2018 Portfolio in Review
As of Q2 2018, T. Rowe Price Associates held 2,648 positions worth $654B, up 4% from $629B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
T. Rowe Price Associates's Q2 2018 filing shows 98 new, 1,625 increased, 741 reduced and 68 closed positions. Its largest new stake was Evergy: 16,595,898 shares worth $932M. The largest sale was Yum! Brands, an estimated $1.4B.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q2 2018 buy was Evergy: 16,595,898 shares worth $932M.
- T. Rowe Price Associates added most to Meta Platforms (Facebook) in Q2 2018, an estimated $1.62B increase.
- T. Rowe Price Associates's biggest Q2 2018 reduction was Yum! Brands, cutting an estimated $1.4B.
- T. Rowe Price Associates fully exited CSRA Inc. in Q2 2018, selling an estimated $912M.
- T. Rowe Price Associates's ten largest holdings make up 21% of its $654B portfolio in Q2 2018.
- T. Rowe Price Associates opened 98 new positions and closed 68 in Q2 2018.
- T. Rowe Price Associates's portfolio value rose 4% quarter-over-quarter to $654B.
Based on T. Rowe Price Associates's 13F filing for Q2 2018, filed 14 Aug 2018.